Compare PLRX & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | TGB |
|---|---|---|
| Founded | 2015 | 1966 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 3.1B |
| IPO Year | 2020 | 2002 |
| Metric | PLRX | TGB |
|---|---|---|
| Price | $1.13 | $8.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.67 | ★ $9.50 |
| AVG Volume (30 Days) | 377.1K | ★ 4.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $71.94 |
| Revenue Next Year | N/A | $26.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $3.66 |
| 52 Week High | $1.95 | $9.82 |
| Indicator | PLRX | TGB |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 52.72 |
| Support Level | $1.11 | $8.22 |
| Resistance Level | $1.21 | $9.08 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 43.48 | 60.18 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Trekor Metals Ltd is a North American copper producer with a development pipeline of minerals projects and properties in Canada and the United States. The company's properties include Gibraltar Mine, Florence Copper, Yellowhead Project, Aley Project, and New Prosperity.